SG/CALL/ROCHE GS/340/0.1/20.12.24 Share Price

Warrant

DE000SU5NY88

Real-time Boerse Frankfurt Warrants 07:04:41 17/05/2024 pm IST
0.098 EUR -2.00% Intraday chart for SG/CALL/ROCHE GS/340/0.1/20.12.24
Current month+132.56%
1 month+58.73%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
17/24/17 0.098 -2.00%
16/24/16 0.1 +100.00%
15/24/15 0.05 +28.21%
14/24/14 0.039 -27.78%
13/24/13 0.054 +14.89%

Real-time Boerse Frankfurt Warrants

Last update May 17, 2024 at 07:04 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Société Générale Société Générale
WKN SU5NY8
ISINDE000SU5NY88
Date issued 12/12/2023
Strike 340 CHF
Maturity 20/12/2024 (217 Days)
Parity 10 : 1
Emission price 0.23
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.22
Lowest since issue 0.012
Delta0.05x
Omega 12.35
Premium44.5x
Gearing231.19x
Moneyness 0.6941
Difference Strike 103.6 CHF
Difference Strike %+30.49%
Spread 0.013
Spread %11.82%
Theoretical value 0.1045
Implied Volatility 26.74 %
Total Loss Probability 96.52 %
Intrinsic value 0.000000
Present value 0.1045
Break even 341.03 €
Theta-0.01x
Vega0.02x
Rho0.01x

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
234.8 CHF
Average target price
279.4 CHF
Spread / Average Target
+18.99%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW